It is presently unclear whether the loss of UL-specific gene expression we observed in our Mllt11 mutants, and tubulinopathies more generally, is primarily because of cytoskeletal dysregulation, or other uncharacterized gene expression pathways functioning downstream of Mllt11. This evidence concerns the gene MLLT11 and tubulinopathy.